February 12, 2025

India’s cosmetics industry is experiencing exponential growth, driven by rising consumer awareness, e-commerce expansion, and increasing demand for over the counter (OTC) beauty and personal care products. However, entering this high-potential market requires strict adherence to evolving regulatory frameworks.

The regulatory pathway for OTC cosmetics in India is governed by the Drugs and Cosmetics Act, 1940 and the Cosmetics Rules, 2020, which establish stringent standards for product safety, quality, labeling, and market authorization.

For manufacturers, importers, and global brands, understanding CDSCO cosmetic registration, compliance requirements, and licensing pathways is essential for seamless market entry and long-term success.

Regulatory Framework for OTC Cosmetics in India

Key Governing Laws and Authorities

Regulatory Body / LawRole in Cosmetic Regulation
Drugs and Cosmetics Act, 1940Primary legislation governing cosmetics safety and approval
Cosmetics Rules, 2020Updated framework for manufacturing, labeling, and import
CDSCO (Central Drugs Standard Control Organization)National authority for import registration and compliance
State Licensing Authorities (SLA)Grant manufacturing licenses and conduct inspections
Bureau of Indian Standards (BIS)Defines quality standards for specific cosmetic categories

The regulatory ecosystem ensures that all cosmetic products, whether manufactured domestically or imported, meet strict safety, efficacy, and quality benchmarks.

What Qualifies as an OTC Cosmetic in India?

Under Indian law, a cosmetic is defined as:

“Any article intended to be rubbed, poured, sprinkled, or applied to the human body for cleansing, beautifying, promoting attractiveness, or altering appearance.”

OTC cosmetics include:

  • Skincare products (creams, lotions, serums)
  • Hair care products (shampoos, conditioners, dyes)
  • Makeup products (foundation, lipstick, mascara)
  • Personal hygiene products (deodorants, face washes)

Important Insight:
Products with therapeutic claims (e.g., anti-acne treatment, skin-lightening with medicinal claims) may be regulated as drugs, requiring a completely different approval pathway.

Key Regulatory Requirements for OTC Cosmetics

1. Manufacturing License

All cosmetic manufacturers must obtain a valid license from the State Licensing Authority (SLA).

License TypeDescription
Own Manufacturing LicenseFor companies producing in their own facility
Loan LicenseFor third-party or contract manufacturing

Key Requirements:

  • GMP-compliant facility
  • Qualified technical staff
  • Product formulation details
  • Quality control systems

2. CDSCO Import Registration

For imported cosmetics, CDSCO registration is mandatory before market entry.

Key Highlights:

  • Covers all product variants and pack sizes
  • Requires submission of detailed product dossier
  • Mandatory for each manufacturing site
RequirementDetails
Application FormCOS-1
Registration CertificateCOS-2
Timeline6–9 months
Validity5 years

3. Ingredient and Safety Compliance

All products must comply with:

  • Ninth Schedule of Cosmetics Rules, 2020
  • Prohibited and restricted ingredient lists
  • Permissible concentration limits
  • International safety benchmarks (EU, ASEAN, etc.)

Trending Compliance Focus (2025–2026):

  • PFAS-free formulations
  • Clean beauty ingredient validation
  • Toxicological risk assessment (TRA)
  • Sustainability and eco-toxicity considerations

4. Cosmetic Labeling Requirements (India)

Labeling compliance is critical for CDSCO approval.

Mandatory Label ElementsDescription
Product NameClear identification
Manufacturer DetailsName and address
Batch NumberTraceability
Manufacturing & Expiry DateShelf-life validation
Ingredient ListINCI format preferred
Net QuantityAs per Legal Metrology
Importer DetailsMandatory for imported products

Non-compliance may lead to product rejection or recall.

5. BIS Standards for Cosmetics

Certain products must comply with Bureau of Indian Standards (BIS):

  • Sunscreens
  • Hair dyes
  • Skin creams

Key Benefit:
Aligning with BIS enhances product credibility and regulatory acceptance.

Step-by-Step OTC Cosmetics Regulatory Pathway

StepProcess
Step 1Product classification (cosmetic vs drug)
Step 2Ingredient safety and compliance check
Step 3Manufacturing license or import registration
Step 4Labeling and claims validation
Step 5Dossier preparation and submission
Step 6CDSCO/SLA review and approval
Step 7Market launch and post-market compliance

Key Challenges in OTC Cosmetics Compliance

1. Dynamic Regulatory Landscape

Frequent updates in Cosmetics Rules 2020 require continuous monitoring.

2. Product Classification Complexity

Misclassification can delay approvals or lead to regulatory rejection.

3. Import Registration Delays

Incomplete dossiers can significantly increase approval timelines.

4. Ingredient Restrictions

Global ingredient bans and restrictions impact formulation strategies.

5. Labeling Compliance Risks

Incorrect labeling is one of the most common causes of non-compliance.

Latest Regulatory Trends (2025–2026)

  • Increased scrutiny on “clean beauty” and “natural claims”
  • Digital compliance and e-labeling initiatives
  • Stronger focus on toxicological safety assessments
  • Alignment with global cosmetic regulations (EU, ASEAN, US)
  • Sustainability and eco-friendly packaging regulations

How Maven Regulatory Solutions Supports OTC Cosmetics Compliance

Maven provides end-to-end regulatory and toxicology solutions tailored for cosmetic companies entering the Indian market.

1. Regulatory & Compliance Services

  • CDSCO cosmetic registration (COS-1, COS-2)
  • Product classification and regulatory strategy
  • Ingredient compliance and toxicological assessment
  • Labeling and claims substantiation

2. Documentation & Dossier Support

  • Product Information File (PIF)
  • Safety Data Sheets (SDS)
  • Cosmetic Product Safety Reports (CPSR)

3. Market Entry Strategy

  • Go-to-market regulatory roadmap
  • Import licensing and approvals
  • Regulatory intelligence and updates

4. Post-Market Compliance

  • Cosmetovigilance support
  • Adverse event monitoring
  • Regulatory updates and lifecycle management

Timeline Overview for OTC Cosmetics Approval

ProcessTimeline
Manufacturing License60–90 days
CDSCO Import Registration6–9 months
Label Review & Compliance2–4 weeks
Full Market Entry6–10 months

Best Practices for Fast-Track Approval

  • Conduct early-stage regulatory assessment
  • Ensure complete and accurate dossier submission
  • Align with global safety standards (EU, ISO, ASEAN)
  • Perform toxicological risk assessments (TRA)
  • Maintain clear and compliant labeling

Frequently Asked Questions 

1. Is CDSCO registration mandatory for all imported cosmetics?

Yes, all imported cosmetics must be registered with CDSCO before sale in India.

2. What is the validity of cosmetic registration in India?

The registration certificate is valid for 5 years.

3. Can OTC cosmetics make therapeutic claims?

No. Products with therapeutic claims may be classified as drugs, requiring separate approval.

4. What are the most common reasons for rejection?

  • Incorrect labeling
  • Incomplete dossier
  • Non-compliant ingredients

5. Do all cosmetics require BIS certification?

Only specific categories like sunscreens and hair dyes require mandatory BIS compliance.

Conclusion

Navigating the OTC cosmetics regulatory pathway in India requires a strategic, compliance-driven approach. With evolving regulations, strict CDSCO requirements, and increasing scrutiny on ingredient safety, companies must adopt proactive regulatory strategies.

Partnering with experienced regulatory experts ensures faster approvals, reduced compliance risks, and successful market entry.

Maven Regulatory Solutions empowers cosmetic brands with end-to-end compliance, toxicological expertise, and regulatory intelligence, helping you launch safe, compliant, and high-quality cosmetic products in India.

Ready to launch your cosmetic product in India?
Connect with Maven Regulatory Solutions today for expert regulatory guidance and seamless CDSCO approval.